The roles of mediator complex in cardiovascular diseases

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 6, 2014, Pages 444-451

  Schiano, Concetta ^a   Casamassimi, Amelia ^b   Vietri, Maria Teresa ^b   Rienzo, Monica ^b   Napoli, Claudio ^a,b  

^a IRCCS SDN   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cardiovascular diseases; Congenital heart diseases; Endothelial progenitor cells; Energy homeostasis; Mediator complex; Pluripotency

Indexed keywords

CYCLIN DEPENDENT KINASE 8; GLUCOSE; MED1 PROTEIN; MED12 PROTEIN; MED13 PROTEIN; MED14 PROTEIN; MED15 PROTEIN; MED19 PROTEIN; MED23 PROTEIN; MED30 PROTEIN; MEDIATOR COMPLEX; UNCLASSIFIED DRUG;

CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; DEREGULATION; ENDOTHELIAL PROGENITOR CELL; GENETIC TRANSCRIPTION; HUMAN; IN VITRO STUDY; LIPID METABOLISM; METABOLIC DISORDER; MISSENSE MUTATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

CARDIOVASCULAR DISEASES; CONGENITAL HEART DISEASES; ENDOTHELIAL PROGENITOR CELLS; ENERGY HOMEOSTASIS; MEDIATOR COMPLEX; PLURIPOTENCY;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; MEDIATOR COMPLEX; MICE;

EID: 84900497024     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.04.012     Document Type: Review

References (86)

1. Liu X., Bushnell D.A., Kornberg R.D. RNA polymerase II transcription: structure and mechanism. Biochim. Biophys. Acta 2013, 1829:2-8.
2. Lee T.I., Young R.A. Transcriptional regulation and its misregulation in disease. Cell 2013, 152:1237-1251.
3. Malik S., Roeder R.G. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet. 2010, 11:761-772.
4. Casamassimi A., Napoli C. Mediator complexes and eukaryotic transcription regulation: an overview. Biochimie 2007, 89:1439-1446.
5. Conaway R.C., Conaway J.W. The Mediator complex and transcription elongation. Biochim. Biophys. Acta 1829, 2013:69-75.
6. Napoli C., Sessa M., Infante T., Casamassimi A. Unraveling framework of the ancestral Mediator complex in human diseases. Biochimie 2012, 94:579-587.
7. Rienzo M., Nagel J., Casamassimi A., Giovane A., Dietzel S., Napoli C. Mediator subunits: gene expression pattern, a novel transcript identification and nuclear localization in human endothelial progenitor cells. Biochim. Biophys. Acta 2010, 1799:487-495.
8. Rienzo M., Casamassimi A., Schiano C., Grimaldi V., Infante T., Napoli C. Distinct alternative splicing patterns of mediator subunit genes during endothelial progenitor cell differentiation. Biochimie 2012, 94:1828-1832.
9. Schiano C., Casamassimi A., Rienzo M., de Nigris F., Sommese L., Napoli C. Involvement of Mediator complex in malignancy. Biochim. Biophys. Acta 1845, 2014:66-83.
10. Mukundan B., Ansari A. Novel role for mediator complex subunit Srb5/Med18 in termination of transcription. J. Biol. Chem. 2011, 286:37053-37057.
11. Huang Y., Li W., Yao X., Lin Q.J., Yin J.W., Liang Y., Heiner M., Tian B., Hui J., Wang G. Mediator complex regulates alternative mRNA processing via the MED23 subunit. Mol. Cell 2012, 45:459-469.
12. Kagey M.H., Newman J.J., Bilodeau S., Zhan Y., Orlando D.A., van Berkum N.L., Ebmeier C.C., Goossens J., Rahl P.B., Levine S.S., Taatjes D.J., Dekker J., Young R.A. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010, 467:430-435.
13. Zhu X., Zhang Y., Bjornsdottir G., Liu Z., Quan A., Costanzo M., Davila Lopez M., Westholm J.O., Ronne H., Boone C., Gustafsson C.M., Myers L.C. Histone modifications influence mediator interactions with chromatin. Nucleic Acids Res. 2011, 39:8342-8354.
14. Conaway R.C., Conaway J.W. Origins and activity of the Mediator complex. Semin. Cell Dev. Biol. 2011, 22:729-734.
15. Galbraith M.D., Donner A.J., Espinosa J.M. CDK8: a positive regulator of transcription. Transcription 2010, 1:4-12.
16. Spaeth J.M., Kim N.H., Boyer T.G. Mediator and human disease. Semin. Cell Dev. Biol. 2011, 22:776-787.
17. Hashimoto S., Boissel S., Zarhrate M., Rio M., Munnich A., Egly J.M., Colleaux L. MED23 mutation links intellectual disability to dysregulation of immediate early gene expression. Science 2011, 333:1161-1163.
18. Kaufmann R., Straussberg R., Mandel H., Fattal-Valevski A., Ben-Zeev B., Naamati A., Shaag A., Zenvirt S., Konen O., Mimouni-Bloch A., Dobyns W.B., Edvardson S., Pines O., Elpeleg O. Infantile cerebral and cerebellar atrophy is associated with a mutation in the MED17 subunit of the transcription preinitiation mediator complex. Am. J. Hum. Genet. 2010, 87:667-670.
19. Graham J.M., Schwartz C.E. MED12 related disorders. Am. J. Med. Genet. A 2013, 161A:2734-2740.
20. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Franco S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Huffman M.D., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Magid D., Marcus G.M., Marelli A., Matchar D.B., McGuire D.K., Mohler E.R., Moy C.S., Mussolino M.E., Nichol G., Paynter N.P., Schreiner P.J., Sorlie P.D., Stein J., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
21. Yin J.W., Wang G. The Mediator complex: a master coordinator of transcription and cell lineage development. Development 2014, 141:977-987.
22. Soutourina J., Wydau S., Ambroise Y., Boschiero C., Werner M. Direct interaction of RNA polymerase II and mediator required for transcription in vivo. Science 2011, 331:1451-1454.
23. Tutter A.V., Kowalski M.P., Baltus G.A., Iourgenko V., Labow M., Li E., Kadam S. Role for Med12 in regulation of Nanog and Nanog target genes. J. Biol. Chem. 2009, 284:3709-3718.
24. Rocha P.P., Scholze M., Bleiss W., Schrewe H. Med12 is essential for early mouse development and for canonical Wnt and Wnt/PCP signaling. Development 2010, 137:2723-2731.
25. Borik S., Simon A.J., Nevo-Caspi Y., Mishali D., Amariglio N., Rechavi G., Paret G. Increased RNA editing in children with cyanotic congenital heart disease. Intensive Care Med. 2011, 37:1664-1671.
26. Amariglio N., Rechavi G. A-to-I RNA editing: a new regulatory mechanism of global gene expression. Blood Cells Mol. Dis. 2007, 39:151-155.
27. Muncke N., Jung C., Rudiger H., Ulmer H., Roeth R., Hubert A., Goldmuntz E., Driscoll D., Goodship J., Schon K., Rappold G. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation 2003, 108:2843-2850.
28. Sato S., Tomomori-Sato C., Parmely T.J., Florens L., Zybailov B., Swanson S.K., Banks C.A., Jin J., Cai Y., Washburn M.P., Conaway J.W., Conaway R.C. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol. Cell 2004, 14:685-691.
29. Samanek M. Congenital heart malformations: prevalence, severity, survival, and quality of life. Cardiol. Young 2000, 10:179-185.
30. Warnes C.A. Transposition of the great arteries. Circulation 2006, 114:2699-2709.
31. Asadollahi R., Oneda B., Sheth F., Azzarello-Burri S., Baldinger R., Joset P., Latal B., Knirsch W., Desai S., Baumer A., Houge G., Andrieux J., Rauch A. Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur. J. Hum. Genet. 2013, 21:1100-1104.
32. Chen C.P., Chen Y.Y., Chern S.R., Wu P.S., Su J.W., Chen Y.T., Chen L.F., Wang W. Prenatal diagnosis and molecular cytogenetic characterization of de novo partial trisomy 12q (12q24.21→qter) and partial monosomy 6q (6q27→qter) associated with coarctation of the aorta, ventriculomegaly and thickened nuchal fold. Gene 2013, 516:138-142.
33. Berti L., Mittler G., Przemeck G.K., Stelzer G., Günzler B., Amati F., Conti E., Dallapiccola B., Hrabé de Angelis M., Novelli G., Meisterernst M. Isolation and characterization of a novel gene from the DiGeorge chromosomal region that encodes for a mediator subunit. Genomics 2001, 74:320-332.
34. Kobrynski L.J., Sullivan K.E. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 2007, 370:1443-1452.
35. Digilio M., Marino B., Capolino R., Dallapiccola B. Clinical manifestations of Deletion 22q11.2 syndrome (DiGeorge/Velo-Cardio-Facial syndrome). Images Paediatr. Cardiol. 2005, 7:23-34.
36. Drew L.J., Crabtree G.W., Markx S., Stark K.L., Chaverneff F., Xu B., Mukai J., Fenelon K., Hsu P.K., Gogos J.A., Karayiorgou M. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. Int. J. Dev. Neurosci. 2011, 29:259-281.
37. Krebs P., Fan W., Chen Y.H., Tobita K., Downes M.R., Wood M.R., Sun L., Li X., Xia Y., Ding N., Spaeth J.M., Moresco E.M., Boyer T.G., Lo C.W., Yen J., Evans R.M., Beutler B. Lethal mitochondrial cardiomyopathy in a hypomorphic Med30 mouse mutant is ameliorated by ketogenic diet. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:19678-19682.
38. Chen W., Roeder R.G. Mediator-dependent nuclear receptor function. Semin. Cell Dev. Biol. 2011, 22:749-758.
39. Poss Z.C., Ebmeier C.C., Taatjes D.J. The Mediator complex and transcription regulation. Crit. Rev. Biochem. Mol. Biol. 2013, 48:575-608.
40. Fondell J.D. The Mediator complex in thyroid hormone receptor action. Biochim. Biophys. Acta 1830, 2013:3867-3875.
41. Ge K., Guermah M., Yuan C.X., Ito M., Wallberg A.E., Spiegelman B.M., Roeder R.G. Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis. Nature 2002, 417:563-567.
42. Ge K., Cho Y.W., Guo H., Hong T.B., Guermah M., Ito M., Yu H., Kalkum M., Roeder R.G. Alternative mechanisms by which mediator subunit MED1/TRAP220 regulates peroxisome proliferator-activated receptor γ-stimulated adipogenesis and target gene expression. Mol. Cell. Biol. 2008, 28:1081-1091.
43. Kang Y.K., Guermah M., Yuan C.X., Roeder R.G. The TRAP/Mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:2642-2647.
44. Yuan C.X., Ito M., Fondell J.D., Fu Z.Y., Roeder R.G. The TRAP220 component of a thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7939-7944.
45. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Näär A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398:824-828.
46. Meyer K.D., Lin S.C., Bernecky C., Gao Y., Taatjes D.J. p53 activates transcription by directing structural shifts in Mediator. Nat. Struct. Mol. Biol. 2010, 17:753-760.
47. Wada O., Oishi H., Takada I., Yanagisawa J., Yano T., Kato S. BRCA1 function mediates a TRAP/DRIP complex through direct interaction with TRAP220. Oncogene 2004, 23:6000-6005.
48. Crawford S.E., Qi C., Misra P., Stellmach V., Rao M.S., Engel J.D., Zhu Y., Reddy J.K. Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors. J. Biol. Chem. 2002, 277:3585-3592.
49. Pandey P.K., Udayakumar T.S., Lin X., Sharma D., Shapiro P.S., Fondell J.D. Activation of TRAP/mediator subunit TRAP220/Med1 is regulated by mitogen-activated protein kinase-dependent phosphorylation. Mol. Cell. Biol. 2005, 25:10695-10710.
50. Chen W., Zhang X., Birsoy K., Roeder R.G. A muscle-specific knockout implicates nuclear receptor coactivator MED1 in the regulation of glucose and energy metabolism. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:10196-10201.
51. Zhu Y., Qi C., Jia Y., Nye J.S., Rao M.S., Reddy J.K. Deletion of PBP/PPARBP, the gene for nuclear receptor coactivator peroxisome proliferator-activated receptor-binding protein, results in embryonic lethality. J. Biol. Chem. 2000, 275:14779-14782.
52. Turner N., Cooney G.J., Kraegen E.W., Bruce C.R. Fatty acid metabolism, energy expenditure and insulin resistance in muscle. J. Endocrinol. 2014, 220:T61-T79.
53. Smith A.G., Muscat G.E. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Int. J. Biochem. Cell Biol. 2005, 37:2047-2063.
54. Becerril S., Rodríguez A., Catalán V., Sáinz N., Ramírez B., Gómez-Ambrosi J., Frühbeck G. Transcriptional analysis of brown adipose tissue in leptin-deficient mice lacking inducible nitric oxide synthase: evidence of the role of Med1 in energy balance. Physiol. Genomics 2012, 44:678-688.
55. Smith A.G., Muscat G.E. Orphan nuclear receptors: therapeutic opportunities in skeletal muscle. Am. J. Physiol. Cell Physiol. 2006, 291:C203-C217.
56. Grueter C.E., van Rooij E., Johnson B.A., DeLeon S.M., Sutherland L.B., Qi X., Gautron L., Elmquist J.K., Bassel-Duby R., Olson E.N. A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 2012, 149:671-683.
57. Latronico M.V., Condorelli G. MicroRNAs and cardiac pathology. Nat. Rev. Cardiol. 2009, 6:419-429.
58. Montgomery R.L., Hullinger T.G., Semus H.M., Dickinson B.A., Seto A.G., Lynch J.M., Stack C., Latimer P.A., Olson E.N., van Rooij E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 2011, 124:1537-1547.
59. Carrer M., Liu N., Grueter C.E., Williams A.H., Frisard M.I., Hulver M.W., Bassel-Duby R., Olson E.N. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:15330-15335.
60. Grontved L., Madsen M.S., Boergesen M., Roeder R.G., Mandrup S. MED14 tethers mediator to the N-terminal domain of peroxisome proliferator-activated receptor gamma and is required for full transcriptional activity and adipogenesis. Mol. Cell. Biol. 2010, 30:2155-2169.
61. Yang F., Vought B.W., Satterlee J.S., Walker A.K., Jim Sun Z.Y., Watts J.L., DeBeaumont R., Saito R.M., Hyberts S.G., Yang S., Macol C., Iyer L., Tjian R., van den Heuvel S., Hart A.C., Wagner G., Näär A.M. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 2006, 442:700-704.
62. Wang W., Huang L., Huang Y., Yin J.W., Berk A.J., Friedman J.M., Wang G. Mediator MED23 links insulin signaling to the adipogenesis transcription cascade. Dev. Cell 2009, 16:764-771.
63. Yin J.W., Liang Y., Park J.Y., Chen D., Yao X., Xiao Q., Liu Z., Jiang B., Fu Y., Bao M., Huang Y., Liu Y., Yan J., Zhu M.S., Yang Z., Gao P., Tian B., Li D., Wang G. The mediator MED23 plays opposing roles in directing smooth muscle cell and adipocyte differentiation. Genes Dev. 2012, 26:2192-2205.
64. Kleber M.E., Seppälä I., Pilz S., Hoffmann M.M., Tomaschitz A., Oksala N., Raitoharju E., Lyytikäinen L.P., Mäkelä K.M., Laaksonen R., Kähönen M., Raitakari O.T., Huang J., Kienreich K., Fahrleitner-Pammer A., Drechsler C., Krane V., Boehm B.O., Koenig W., Wanner C., Lehtimäki T., März W., Meinitzer A. Genome-Wide Association Study identifies three genomic loci significantly associated with serum levels of homoarginine - the AtheroRemo consortium. Circ. Cardiovasc. Genet. 2013, 6:505-513.
65. Han E.H., Rha G.B., Chi Y.I. MED25 is a mediator component of HNF4α-driven transcription leading to insulin secretion in pancreatic beta-cells. PLoS One 2012, 7:e44007.
66. Miura A., Yamagata K., Kakei M., Hatakeyama H., Takahashi N., Fukui K., Nammo T., Yoneda K., Inoue Y., Sladek F.M., Magnuson M.A., Kasai H., Miyagawa J., Gonzalez F.J., Shimomura I. Hepatocyte nuclear factor-4alpha is essential for glucose-stimulated insulin secretion by pancreatic beta-cells. J. Biol. Chem. 2006, 281:5246-5257.
67. Rana R., Surapureddi S., Kam W., Ferguson S., Goldstein J.A. Med25 is required for RNA polymerase II recruitment to specific promoters, thus regulating xenobiotic and lipid metabolism in human liver. Mol. Cell. Biol. 2011, 31:466-481.
68. Yamagata K., Furuta H., Oda N., Kaisaki P.J., Menzel S., Cox N.J., Fajans S.S., Signorini S., Stoffel M., Bell G.I. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996, 384:458-460.
69. Zhao X., Feng D., Wang Q., Abdulla A., Xie X.J., Zhou J., Sun Y., Yang E.S., Liu L.P., Vaitheesvaran B., Bridges L., Kurland I.J., Strich R., Ni J.Q., Wang C., Ericsson J., Pessin J.E., Ji J.Y., Yang F. Regulation of lipogenesis by cyclin-dependent kinase8-mediated control of SREBP-1. J. Clin. Investig. 2012, 122:2417-2427.
70. Mousley C.J., Yuan P., Gaur N.A., Trettin K.D., Nile A.H., Deminoff S.J., Dewar B.J., Wolpert M., Macdonald J.M., Herman P.K., Hinnebusch A.G., Bankaitis V.A. A sterol-binding protein integrates endosomal lipid metabolism with TOR signaling and nitrogen sensing. Cell 2012, 148:702-715.
71. Ma T., Xie M., Laurent T., Ding S. Progress in the reprogramming of somatic cells. Circ. Res. 2013, 112:562-574.
72. Apostolou E., Ferrari F., Walsh R.M., Bar-Nur O., Stadtfeld M., Cheloufi S., Stuart H.T., Polo J.M., Ohsumi T.K., Borowsky M.L., Kharchenko P.V., Park P.J., Hochedlinger K. Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming. Cell Stem Cell 2013, 12:699-712.
73. Wei Z., Gao F., Kim S., Yang H., Lyu J., An W., Wang K., Lu W. Klf4 organizes long-range chromosomal interactions with the oct4 locus in reprogramming and pluripotency. Cell Stem Cell 2013, 13:36-47.
74. Whyte W.A., Orlando D.A., Hnisz D., Abraham B.J., Lin C.Y., Kagey M.H., Rahl P.B., Lee T.I., Young R.A. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
75. Hnisz D., Abraham B.J., Lee T.I., Lau A., Saint-André V., Sigova A.A., Hoke H.A., Young R.A. Super-enhancers in the control of cell identity and disease. Cell 2013, 155:934-947.
76. Grimaldi V., Mancini F.P., Casamassimi A., Al-Omran M., Zullo A., Infante T., Napoli C. Potential benefits of cell therapy in coronary heart disease. J. Cardiol. 2013, 62:267-276.
77. Casamassimi A., Grimaldi V., Infante T., Al-Omran M., Crudele V., Napoli C. Adult stem cells and the clinical arena: are we able to widely use this therapy in patients with chronic limbs arteriopathy and ischemic ulcers without possibility of revascularization?. Cardiovasc. Hematol. Agents Med. Chem. 2012, 10:99-108.
78. Napoli C., Hayashi T., Cacciatore F., Casamassimi A., Casini C., Al-Omran M., Ignarro L.J. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. Atherosclerosis 2011, 215:9-22.
79. Yoder M.C. Human endothelial progenitor cells. Cold Spring Harb. Perspect. Med. 2012, 2:a006692.
80. Kalsotra A., Cooper T.A. Functional consequences of developmentally regulated alternative splicing. Nat. Rev. Genet. 2011, 12:715-729.
81. Gabut M., Samavarchi-Tehrani P., Wang X., Slobodeniuc V., O'Hanlon D., Sung H.K., Alvarez M., Talukder S., Pan Q., Mazzoni E.O., Nedelec S., Wichterle H., Woltjen K., Hughes T.R., Zandstra P.W., Nagy A., Wrana J.L., Blencowe B.J. An alternative splicing switch regulates embryonic stem cell pluripotency and reprogramming. Cell 2011, 147:132-146.
82. Salomonis N., Schlieve C.R., Pereira L., Wahlquist C., Colas A., Zambon A.C., Vranizan K., Spindler M.J., Pico A.R., Cline M.S., Clark T.A., Williams A., Blume J.E., Samal E., Mercola M., Merrill B.J., Conklin B.R. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:10514-10519.
83. Costa V., Aprile M., Esposito R., Ciccodicola A. RNA-Seq and human complex diseases: recent accomplishments and future perspectives. Eur. J. Hum. Genet. 2013, 21:134-142.
84. Schneider E.V., Böttcher J., Huber R., Maskos K., Neumann L. Structure-kinetic relationship study of CDK8/CycC specific compounds. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8081-8086.
85. Schneider E.V., Böttcher J., Blaesse M., Neumann L., Huber R., Maskos K. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder. J. Mol. Biol. 2011, 412:251-266.
86. He S.B., Yuan Y., Wang L., Yu M.J., Zhu Y.B., Zhu X.G. Effects of cyclin-dependent kinase 8 specific siRNA on the proliferation and apoptosis of colon cancer cells. J. Exp. Clin. Cancer Res. 2011, 30:109.